Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Consolidated Net Income (2020 - 2025)

KORU Medical Systems has reported Consolidated Net Income over the past 11 years, most recently at -$486856.0 for Q4 2025.

  • Quarterly results put Consolidated Net Income at -$486856.0 for Q4 2025, up 68.76% from a year ago — trailing twelve months through Dec 2025 was -$2.6 million (up 56.5% YoY), and the annual figure for FY2025 was -$2.6 million, up 56.52%.
  • Consolidated Net Income for Q4 2025 was -$486856.0 at KORU Medical Systems, up from -$777966.0 in the prior quarter.
  • Over the last five years, Consolidated Net Income for KRMD hit a ceiling of -$206867.0 in Q2 2025 and a floor of -$7.5 million in Q4 2023.
  • Median Consolidated Net Income over the past 5 years was -$1.3 million (2021), compared with a mean of -$1.8 million.
  • Biggest five-year swings in Consolidated Net Income: plummeted 538.96% in 2021 and later skyrocketed 79.13% in 2024.
  • KORU Medical Systems' Consolidated Net Income stood at -$1.1 million in 2021, then plummeted by 85.02% to -$2.0 million in 2022, then tumbled by 277.7% to -$7.5 million in 2023, then skyrocketed by 79.13% to -$1.6 million in 2024, then soared by 68.76% to -$486856.0 in 2025.
  • The last three reported values for Consolidated Net Income were -$486856.0 (Q4 2025), -$777966.0 (Q3 2025), and -$206867.0 (Q2 2025) per Business Quant data.